Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $2.98 Analyst target: $4.90 Upside: 64.43%
Cypherpunk Technologies Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. The company is headquartered in Cambridge, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.